Ontario Institute for Cancer Research (OICR)
Innovation to Implementation (I2I) Program
For More Information
For complete program details, please visit the Innovation to Implementation (I2I) program web-page.
To accelerate translational cancer research so that precise, impactful and cost-effective treatments can benefit cancer patients, OICR has implemented a new Clinical Translation Pathway (CTP) to support preclinical, clinical, and convergent research. The CTP consists of four separate funding streams and is currently inviting applications for the Innovation to Implementation (I2I) funding opportunity which is focused on overcoming barriers to the mobilization, or uptake, of knowledge required to facilitate adoption of research into policy or healthcare. OICR is committed to providing research funding to help support a sustainable health system that enables fair and equitable access to cancer interventions.
Examples of eligible studies include:
- Studies that facilitate movement of research-generated knowledge to actual application of such knowledge in population health, screening, or clinical practice settings
- Studies that enable engagement of new users, including patients, along the translational continuum to advance the research into clinical settings
- Studies that adapt a research tool for use in cancer prevention, clinical settings or clinical trials
- Studies that conduct economic analysis or generate real-world evidence required to inform adoption of research into policy or routine healthcare
- Studies evaluating the comparative real-world clinical- and cost‐effectiveness of interventions
- Knowledge translation activities that will advance the adoption of research into policy or routine healthcare
OICR invites applications from investigators at Ontario academic centres, hospital research institutes or other government research institutions. There is no limit to the number of applications investigators are eligible to submit as PI or Co-PI. OICR is focused on developing and supporting the next generation of cancer researchers, and strongly encourages applicants to include early career investigators/clinicians as part of the project team. Further, teams should consider the inclusion of a physician and/or a biostatistician for relevant projects. This program does not require previous OICR funding support in order to be eligible.
Up to $100,000 per year, inclusive of overhead, for a maximum of two years. OICR funding is only tenable in Ontario. For-profit entities are not eligible to receive OICR funding.
OICR provides 30% overhead on eligible expenses.
Applications selected for funding will be provided with a funding term of up to two years, starting April 1, 2023, and ending no later than March 31, 2025.
For an overview of the funding opportunity, consider attending a one-hour, virtual info session on September 20, 2022, 11 a.m. to 12 p.m. ET. This session will be recorded and posted on the OICR web-page for viewing at a later date. To register for the session, please visit the Session Registration web-page.
If College-level review is required, your College will communicate its earlier internal deadlines.
Applicant to submit LOI using OICR's Grant Management System, ReportNet.
The LOI results will be communicated by mid November, 2022. Qualified applicants will be invited to submit a full application. Please inform firstname.lastname@example.org if you are invited to submit a full application.
Applicant to submit full application using OICR's Grant Management System, ReportNet.
If successful, applicants will be notified by March 2023.
How to Apply
LOIs and full applications are to be submitted using ReportNet, OICR’s online system for managing grants and awards.